Antibodies that detect Futuximab can be used in several scientific applications, including ELISA and SDS-PAGE. This Human recombinant monoclonal antibody targets Futuximab, and has been validated in experiments with 1 image featured in our data gallery.
Browse primary antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and other applications. Antibodies with Advanced Verification data have been validated for specificity to ensure that the antibody binds to the antigen stated. If you cannot find the antibody you're looking for, contact us today to develop custom antibodies for specific targets, species and applications. Custom conjugation and purification services are available as well.
靶标信息
Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
同义词
DS 992; Sym 004 (combination of modotuximab and futuximab)
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party
scientific content. Neither the content nor the BenchSci technology and processes for
selection have been evaluated by us; we are providing them as-is and without warranty of any kind,
including for use or application of the Thermo Fisher Scientific products presented.